3629 results for «695»

Filter By

3629 results

Physiological vs. anatomical assessment of multivessel disease patients

21 May 2026 – From EuroPCR 2026

This session delves into the comparative benefits of physiological versus anatomical assessment in patients with multivessel coronary disease, focusing particularly on myocardial infarction cases. Attendees will explore how coronary physiology can guide complete revascularisation, the added value of physiological assessment beyond conventional angiography, and the selection...

Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy

21 May 2026 – From EuroPCR 2026

This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...

Complex PCI - Best cases from PCR Global Interventional Academy - Part 2

21 May 2026 – From EuroPCR 2026

This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...

Refining PCI plannings and decision-making with novel technologies

21 May 2026 – From EuroPCR 2026

This session highlights cutting-edge technologies that enhance PCI planning and decision-making. It covers the clinical populations benefiting from QFR-guided revascularisation, prognostic insights from radial wall strain in DCB-treated vessels, and advances in artificial intelligence and machine learning to assess ischemia and predict PCI outcomes, especially in...

DCB as a key player in the management of complex coronary lesions

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...

Optimising TAVI care pathways

21 May 2026 – From EuroPCR 2026

This session examines innovations in TAVI care pathways aimed at improving patient outcomes and healthcare efficiency. Topics include large-scale transatlantic data on day-case TAVI, standardized ECG conduction algorithms reducing hospital stay, nurse-led structured pathways, feasibility of very early discharge, and urgent outpatient TAVI for severe aortic...

Optimising the results of non-left main bifurcation PCI

21 May 2026 – From EuroPCR 2026

This session focuses on optimizing outcomes in non-left main bifurcation PCI by emphasizing lesion preparation and stent sizing guided by intravascular imaging. It integrates physiological and imaging assessments for confident final result evaluation and discusses criteria for selecting upfront two-stent strategies in bifurcation lesions.

A new horizon in left main and multivessel PCI

21 May 2026 – From EuroPCR 2026

This session explores new horizons in managing left main and multivessel coronary artery disease with PCI. It covers comprehensive evaluation techniques, including physiology and imaging assessments, and advanced PCI strategies for challenging eccentric and heavily calcified lesions. Case presentations from diverse clinical contexts illustrate decision-making and...

Advancing TAVI practice

21 May 2026 – From EuroPCR 2026

Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.

Innovations in TAVI: TAVI 2.0

21 May 2026 – From EuroPCR 2026

This session presents cutting-edge advancements in transcatheter aortic valve implantation (TAVI), highlighting the TAVI 2.0 era. It encompasses innovative techniques such as percutaneous and non-fluoroscopic TAVR guided by transthoracic echocardiography (TTE), novel alternative access via the left subscapular approach, and patient-tailored commissural alignment assessed through CT...

NSTEMI: when everything does not go as planned

21 May 2026 – From EuroPCR 2026

This session presents complex cases of NSTEMI where unexpected challenges arise during intervention. It provides a comprehensive review of complication management strategies, including coronary perforation techniques. Through detailed case analyses from diverse centers, attendees gain practical insights into troubleshooting and treatment adaptations essential for managing difficult...

TAVI in heart failure is possible

21 May 2026 – From EuroPCR 2026

This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions...

Post myocardial infarction and iatrogenic VSDs: case-based decision taking

21 May 2026 – From EuroPCR 2026

This session focuses on decision-making in post-myocardial infarction and iatrogenic ventricular septal defects (VSDs) through illustrative cases. It covers transcatheter closure techniques, zero contrast interventions guided by echocardiography, and innovative approaches to late and residual VSDs following congenital heart surgery.

Challenging clinical scenarios in STEMI

21 May 2026 – From EuroPCR 2026

This session explores challenging clinical scenarios in STEMI, including coronary embolisation from aortic valve vegetation, blunt chest trauma-related STEMI, intramural hematoma diagnostics with multimodality imaging, acute stent thrombosis during dengue recovery, and advanced clot removal techniques beyond standard aspiration devices.

CTO ADVANCED Level III: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

21 May 2026 – From EuroPCR 2026

This advanced educational session features live complex chronic total occlusion (CTO) PCI cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel. It emphasizes optimizing strategy selection, procedural efficiency across diverse CTO anatomies, and integrating advanced techniques into routine complex practice.

Left main PCI: technical limits

21 May 2026 – From EuroPCR 2026

This comprehensive session reviews the technical challenges and current strategies in left main PCI. Topics include provisional versus DK crush approaches, IVUS-based assessment of ostial LAD lesions, long-term outcomes of DCB use in left main bifurcations, stenting strategies for complex lesions, and the prognostic value of...

Let's train! How to build a functional training programme for our team?

21 May 2026 – From EuroPCR 2026

This session addresses the common barriers to effective cathlab training and offers a structured approach to building a functional training program tailored to your team's needs. Emphasis is placed on sustainable training models, teamwork, and evaluation methods to ensure competency development and continuous improvement in interventional...

TAVI procedural complications - Part 9: coronary occlusion, difficult aortic valve crossing and more

21 May 2026 – From EuroPCR 2026

Explore the management of complex TAVI procedural complications, including coronary occlusion and difficult valve crossing. This session presents innovative bailout techniques, diagnostic challenges, and case-based discussions highlighting acute coronary syndrome post-TAVI and nuanced approaches to valve-in-valve interventions.

Mitral interventions: procedural risk assessment and interventions

21 May 2026 – From EuroPCR 2026

Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.

Left main complications - Part 1

21 May 2026 – From EuroPCR 2026

Focus on managing complications related to left main coronary interventions, with detailed case analyses addressing procedural pitfalls, iatrogenic dissections, and unexpected imaging challenges.

Didn’t find what you were looking for?